LINEͧãÄɲÃ

¥á¥ë¥Þ¥¬ÅÐÏ¿

´¶À÷¾ÉÂкö¤òŰÄ줷¡¢Åö±¡¤ÏÄ̾ïÄ̤ê¿ÇÎŤ·¤Æ¤ª¤ê¤Þ¤¹¡£³§¤µ¤Þ¤Ë°Â¿´¤·¤Æ¤´ÍøÍѤ¤¤¿¤À¤±¤Þ¤¹¤è¤¦¡¢¥³¥í¥Ê¥¦¥¤¥ë¥¹´¶À÷Ëɻߤˤª¤±¤ë¼è¤êÁȤߤˤĤ¤¤Æ¡¢¤´Íý²ò¤È¤´¶¨ÎϤò»ò¤ê¤Þ¤¹¤è¤¦¤ª´ê¤¤¿½¤·¾å¤²¤Þ¤¹¡£

ºÆÀ¸°åÎŤΰÂÁ´À­¤Ë¤Ä¤¤¤Æ

RD¥¯¥ê¥Ë¥Ã¥¯È©¤ÎºÆÀ¸°åÎŤˤĤ¤¤ÆºÆÀ¸°åÎŤΰÂÁ´À­¤Ë¤Ä¤¤¤Æ

¼ºÇÔ¤äÉûºîÍѤΥꥹ¥¯¤¬¶Ë¤á¤ÆÄ㤤

¼ºÇÔ¤äÉûºîÍѤΥꥹ¥¯¤¬Ä㤤

È©¤ÎºÆÀ¸°åÎŤˤè¤ë¼£ÎŤϡ¢¼«Ê¬¼«¿È¤ÎºÙ˦¤òÁý¤ä¤·¤ÆÌ᤹¤À¤±¤Ê¤Î¤Ç¡¢¼£ÎŤÎÍ­¸úÀ­¤À¤±¤Ç¤Ê¤¯ÉûºîÍѤΥꥹ¥¯¤¬¶Ë¤á¤ÆÄ㤤¼£ÎÅË¡¤Ç¤¹¡£
¤Þ¤¿¡¢È©ºÆÀ¸°åÎÅ¡ÊÈ©ºÙ˦Êä½¼ÎÅË¡¡Ë¤Ï¥¢¥á¥ê¥«¤ÎIsolagen¼Ò¤¬1995ǯ¤ËÈ©¤ÎÀ°ÍưåÎÅ¡ÊÈþÍÆÌÜŪ¡Ë¤È¤·¤Æ¼ÂÍѲ½¤·¡¢¤½¤Î°ÂÁ´À­¡¦¼£ÎŤÎÍ­¸úÀ­¤Ë¤è¤êFDA¤«¤é¼£ÎŤȤ·¤Æ¤Î¹â¤¤É¾²Á¤Èǧ¾Ú¤òÆÀ¤Æ¤ª¤ê¤Þ¤¹¡£
RD¥¯¥ê¥Ë¥Ã¥¯¤Ç¤Ï¹¹¤Ë¸·³Ê¤Ê´ð½à¤Ë´ð¤Å¤­¥¨¥ó¥É¥È¥­¥·¥ó¸¡ºº¤äDNA¸¡ºº¤Ë¤è¤ë¸Ä¿Í¼±Ê̤ò¹Ô¤Ê¤¦»ö¤Ç½¾Íè¤ÎÊýË¡¤è¤ê¹â¤¤°ÂÁ´À­¤òÍ­¤·¤Æ¤ª¤ê¤Þ¤¹¡£

¢¨FDA¡Ê¥¢¥á¥ê¥«¤Ë¤ª¤±¤ë°åÌôÉÊ¡¦°åÎŵ¡´ï¤Ê¤É¤Î°ÂÁ´À­¡¦Í­¸úÀ­¤òǧ¾Ú¤¹¤ëµ¡´Ø¡§ÆüËܤθüÀ¸¾Ê¤ËÁêÅö¡Ë

Ë­É٤ʾÉÎã¿ô¤Ë´ð¤Å¤¯·Ð¸³¤È¼ÂÀÓ

¾ÉÎã¿ô20,000·ï°Ê¾å¤Î¼ÂÀÓ¡£
2003ǯ¡¢ÆüËܤǽé¤á¤Æ¤ÎÈ©¤ÎºÆÀ¸°åÎÅÀìÌ祯¥ê¥Ë¥Ã¥¯¤È¤·¤Æ¡¢»ºÀ¼¤ò¤¢¤²¤Þ¤·¤¿¡£

2019ǯ¸½ºß¡¢RD¥¯¥ê¥Ë¥Ã¥¯¤Ç¤ÏÈ©¤ÎºÆÀ¸°åÎŤˤª¤¤¤Æ20,000¾ÉÎã¤È¤¤¤¦Ë­É٤ʾÉÎã¿ô¤ò·Ð¸³¤·¤Æ¤ª¤ê¤Þ¤¹¡£

RD¥¯¥ê¥Ë¥Ã¥¯¤Î¾ÉÎã¼Ì¿¿¤Ï¤³¤Á¤é

ÀìÌç»ÜÀߤǤÎŰÄ줷¤¿ÉʼÁ´ÉÍýÂÎÀ©

¼ºÇÔ¤äÉûºîÍѤΥꥹ¥¯¤¬Ä㤤

È©¤ÎºÆÀ¸°åÎŤϡ¢ºÙ˦ÇÝÍÜ¥»¥ó¥¿¡¼¡ÊCPC¡Ë¤È¸Æ¤Ð¤ì¤ëÀìÌç¤Î»ÜÀߤ¬¤Ê¤±¤ì¤ÐÄ󶡤Ǥ­¤Þ¤»¤ó¡£
¤¢¤Ê¤¿¤«¤é¤ªÍ¤«¤ê¤·¤¿ÈéÉæ¤Ï¿×®¤Ë¡ÖÆÃÄêºÙ˦²Ã¹©ÊªÀ½Â¤»ö¶È¼Ô¡×¤Ç¤¢¤ë³ô¼°²ñ¼Ò¥»¥ë¥Ð¥ó¥¯[»ÜÀßÈֹ桧FA3150017]¤ÎºÙ˦ÇÝÍÜ¥»¥ó¥¿¡¼¡ÊCPC¡Ë¤ØÈÂÆþ¤µ¤ì¤Þ¤¹¡£
Ê¿À®26ǯ¤Ë»Ü¹Ô¤µ¤ì¤¿¡ØºÆÀ¸°åÎÅÅù¤Î°ÂÁ´À­¤Î³ÎÊÝÅù¤Ë´Ø¤¹¤ëˡΧ¡Ù¤Ë´ð¤Å¤¯¡¢Å°Ä줷¤¿±¿±Ä´ÉÍýÂÎÀ©¤Î¸µ¡¢ºÙ˦¤ÎÉʼÁ´ÉÍý¤ò¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£

ºÙ˦ÇÝÍÜ¥»¥ó¥¿¡¼¡ÊCPC¡Ë¤Ë¤Ä¤¤¤Æ

°åÎŵ»½Ñ¤ÎÇØ·Ê

³ô¼°²ñ¼Ò¥»¥ë¥Ð¥ó¥¯¤Îµ»½ÑÄ󶡤ˤè¤ê¡¢È©¤ÎºÆÀ¸°åÎŤϹԤï¤ì¤Æ¤¤¤Þ¤¹¡£

È©¤ÎºÆÀ¸°åÎŤϡ¢³ô¼°²ñ¼Ò¥»¥ë¥Ð¥ó¥¯¤Îµ»½ÑÄ󶡤ˤè¤ê¡¢ÈþÍÆ°åÎŤËÍѤ¤¤é¤ì¤Þ¤¹¡£¤³¤ÎÈþÍÆ°åÎŤϡ¢³ô¼°²ñ¼Ò¥»¥ë¥Ð¥ó¥¯¤Î¾¡¢¸¦µæµ¡´Ø¡¢°åÎŵ¡´Ø¡¢Ê£¹ç·¿ÇÝÍÜÈéÉæ¤ÎÆÃµö¤òÍ­¤¹¤ëÅ쳤Âç³Ø°å³ØÉô¤ÎÊ£¹çÂΤθ¦µæ¤«¤éÀ¸¤Þ¤ì¤¿ºÆÀ¸°åÎŤǤ¹¡£

È©¤ÎºÆÀ¸°åÎŤΰÂÁ´À­¤È¼ÂÀÓ

30ǯ°Ê¾å¤ÎÎò»Ë¤¢¤ëºÆÀ¸°åÎÅ

¼ºÇÔ¤äÉûºîÍѤΥꥹ¥¯¤¬Ä㤤

È©¤ÎºÆÀ¸°åÎŤȤϡ¢¤¢¤Ê¤¿¤ÎÈ©ºÙ˦¤ò»È¤¤¡¢¸º¤Ã¤Æ¤·¤Þ¤Ã¤¿È©ºÙ˦¤òºÆÀ¸¤¹¤ë¤³¤È¡£ºÆÀ¸°åÎŤÎÎò»Ë¤Ï¡¢ÈéÉæ¤ÎʬÌî¤Ç1970ǯÂå¤Ë»Ï¤Þ¤ê¤Þ¤·¤¿¡£
1995ǯ¤Ë¡¢¥¢¥á¥ê¥«¤ÇÀþ°Ý²êºÙ˦¤òÇÝÍܤ·¡¢ÈéÉæ¤ËÃí¼Í¤¹¤ë¼£ÎŤ¬¹Ô¤ï¤ì¡¢¿¿ÈéÀþ°Ý²êºÙ˦¤òÁý¤ä¤¹¤Î¤ËÍ­¸ú¤Ç¤¢¤ë¤³¤È¤¬¤ï¤«¤ê¤Þ¤·¤¿¡£

ÆüËܤˤª¤±¤ëÈ©ºÆÀ¸°åÎŤΥѥ¤¥ª¥Ë¥¢¤È¤·¤Æ¤Î¼ÂÀÓ

2003ǯ¡¢RD¥¯¥ê¥Ë¥Ã¥¯¤ÏÆüËܤǽé¤á¤Æ¡ÖÈ©ºÆÀ¸°åΚפˤè¤ë¿ÇÎŤò³«»Ï¤·¤Þ¤·¤¿¡£¤½¤ÎÀè¿ÊÀ­¤Ëɾ²Á¤ò¤¤¤¿¤À¤­¡¢RD¥¯¥ê¥Ë¥Ã¥¯¤Î¼ÂÀӤϳزñ¡¦¥á¥Ç¥£¥¢¤òÄ̤¸¤ÆÈ¯É½¤·¤Æ¤ª¤ê¤Þ¤¹¡£

È©¤ÎºÆÀ¸°åÎŤμ£ÎŤÎÎò»Ë

  • 1999ǯ

    Å쳤Âç³Ø·ÁÀ®³°²Ê¥°¥ë¡¼¥×¤Ç¡¢ËÜË®½é¤ÎÈ©¤ÎºÆÀ¸°åÎŤò¼Â»Ü

  • 2003ǯ

    Å쳤Âç³Ø·ÁÀ®³°²Ê¥°¥ë¡¼¥×¤¬¡¢ºÆÀ¸°åÎŻٱç´ë¶È¤òÀßΩ¡£¥¯¥ê¥Ë¥Ã¥¯Ê»ÀߤκÆÀ¸°åÎÅÍÑÀßÈ÷¤ò¹½ÃÛ¤·¡¢¹ñÆâ½é¤È¤Ê¤ë°ìÈÌ¿ÇÎŤò³«»Ï¡£

  • 2004ǯ

    ºÆÀ¸°åÎŻٱç´ë¶È¤¬³ô¼°²ñ¼Ò¤ËÁÈ¿¥Êѹ¹¡£

  • 2006ǯ

    ¾ÉÎ㤬400̾¤ò±Û¤¨¡¢¼£Îż굻¤¬°ìÈ̲½¤¹¤ë¡£

  • 2008ǯ

    ¾ÉÎ㤬1500̾¤ò±Û¤¨¤ë¡£

  • 2017ǯ

    ¾ÉÎ㤬6000̾¤òͤ¨¤ë¾ÉÎã¿ô¤È¤Ê¤ê¡¢¸ú²Ì¤ò¼Â´¶¤µ¤ì¤¿Â¿¤¯¤ÎÊý¤¬¥ê¥Ô¡¼¥¿¡¼¤È¤Ê¤ë¡£

¿¿ÈéÀþ°Ý²êºÙ˦¡ÊÈ©ºÙ˦¡Ë¤òÍѤ¤¤¿¡ÖÈ©¤ÎºÆÀ¸°åΚפϡ¢º¬µò¡Ê¥¨¥Ó¥Ç¥ó¥¹¡Ë¤Ë´ð¤Å¤¯°åÎŤǤ¹

ºÇ¶á¡¢º¬µò¡Ê¥¨¥Ó¥Ç¥ó¥¹¡Ë¤Ë˳¤·¤¤°å΍θºß¤¬¡¢ÆÃ¤Ë¤¬¤ó¼£ÎÅ¡ÊÌȱֺÙ˦ÎÅË¡¡¢°äÅÁ»Ò¼£ÎšˤǼҲñÌäÂê²½¤·¤Æ¤¤¤Þ¤¹¡£
³«È¯¤µ¤ì¤¿¤Ð¤«¤ê¤Î¡Ö¿·¤·¤¤¼£ÎÅË¡¡×¤Ï¡¢»þ´Ö¤ò¤«¤±¾ÉÎã¿ô¤ò½Å¤Í¤ë¤³¤È¤Ç¥¨¥Ó¥Ç¥ó¥¹¤òÃßÀѤ·¤Æ¤æ¤­¤Þ¤¹¡£ÅöÁ³¡¢¡Ö¿·¤·¤¤¼£ÎÅË¡¡×¤ÎÃæ¤Ë¤Ï¡¢¥¨¥Ó¥Ç¥ó¥¹¤òÃßÀѤǤ­¤º¾Ã¤¨¤Æ¤æ¤¯¼£ÎŤ⤢¤ê¤Þ¤¹¡£¤à¤·¤í¡¢¥¨¥Ó¥Ç¥ó¥¹¤¬Ìµ¤¤¤È¤·¤Æ¾Ã¤¨¤Æ¤æ¤¯¼£ÎŤÎÊý¤¬°µÅÝŪ¤Ë¿ô¤Ï¿¤¤¤Î¤Ç¤¹¡£À±¤Î¿ô¤Û¤É¤¢¤ë¡Ö¿·¤·¤¤¼£ÎÅË¡¡×¤¬¥¨¥Ó¥Ç¥ó¥¹¤È¤¤¤¦¤Õ¤ë¤¤¤Ë¤«¤±¤é¤ì¡¢Áª¤ê¤¹¤°¤é¤ì¤¿¼£ÎŤΤߤ¬É¸½à¼£ÎŤȸƤФì¤Þ¤¹¡£
»Äǰ¤Ê¤³¤È¤Ë¡Öɸ½à¡×¤È¤¤¤¦ÆüËܸì¤Ë¤Ï¡ÖÊ¡פȤ«¡ÖÊ¿ËޡפȤ«¡Ö¾¾ÃÝÇߤÎÃݡפȤ¤¤¦¥Ë¥å¥¢¥ó¥¹¤¬¤¢¤ê¤Þ¤¹¡£¤³¤Î¥Ë¥å¥¢¥ó¥¹¤Î¤»¤¤¤Ç¡Öɸ½à¼£ÎšפȤϡ¢¡ÖºÇÎɤμ£ÎŤˤϵڤФʤ¤¼£Îšפ⤷¤¯¤Ï¡¢¡ÖºÇÎɤǤϤʤ¤Ê¤ߤμ£ÎšפȤ¤¤¦¸í¤Ã¤¿´¶³Ð¤ò²æ¡¹¤ËÊú¤«¤»¤Æ¤·¤Þ¤¦¤Î¤Ç¤¹¡£
¤·¤«¤·¡¢¡Öɸ½à¼£ÎšפȤϱѸì¤Î¡Östandard therapy¡×¤òµ¡³£Åª¤ËÌõ¤·¤¿¤À¤±¤Ç¡¢¤½¤â¤½¤â¡Östandard therapy¡×¤Ë¤Ï¡¢¡ÖºÇÎɤμ£Îšס¢¡ÖºÇ¤âÍ¥½¨¤Ê¼£ÎšפȤ¤¤¦¥Ë¥å¥¢¥ó¥¹¤¬´Þ¤Þ¤ì¤Æ¤¤¤Þ¤¹¡£¡Östandard therapy¡×¤È¤Ï¡¢»þ´Ö¤ò¤«¤±¡¢Â¿¤¯¤ÎÀìÌç²È¤Î¸·¤·¤¤Ìܤ˻¯¤µ¤ì¥¨¥Ó¥Ç¥ó¥¹¤òÃßÀѤ·¤¿¼£ÎÅ¡¢¤¹¤Ê¤ï¤Á¡ÖºÇÎɤμ£Îšס¢¡ÖºÇ¤âÍ¥½¨¤Ê¼£ÎšפʤΤǤ¹¡£

¼£ÎŤ˴ؤ¹¤ëº¬µòÏÀʸ¤è¤ê

1) Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg. 1999 Jul-Sep; 1(3):165-70.
1999ǯȯɽ¡£ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤¬¡¢´é¤Î¤·¤ï¡¦¤¿¤ë¤ß¡¢´ÙËפʤɤËÍ­¸ú¤«10¿Í¤ÎÀ®¿Í¤ËÂФ·¤Æ(age range, 24-69 years)¼£ÎŤò¹Ô¤¤¡¢6¥õ·î¸å¤Ë¸ú²ÌȽÄê¡Ê¼Ì¿¿¡¢ÈéÉæ¤Î¥·¥ê¥³¥óÃò·¿ÌÏ·¿¡Ë¤È¡¢¼£ÎÅÉô°Ì¤Î¸²Èù¶ÀŪ¤Ê¸¡ºº¤ò¹Ô¤Ã¤¿¡£·ë²Ì¡¢10¿ÍÃæ9¿Í¤¬60%¡Ý100%¤Î²þÁ±¤ò¼¨¤·¤¿¡£¤¹¤Ê¤ï¤Á¡¢¤·¤ï¤¬¸º¾¯¤·¼£ÎÅÉô°Ì¤Î¿¿È饳¥é¡¼¥²¥ó¤¬Áý²Ã¤·¤Æ¤¤¤¿¤¿¤á¡¢¤³¤Î¼£ÎŤÏÍ­¸ú¤Ç¤¢¤ë¤È·ëÏÀ¤Ç¤­¤¿¡£
»²¹ÍÏÀʸ01¡ä

2) Boss WK Jr, Usal H, Chernoff G, Keller GS, Lask GP, Fodor PB. Autologous cultured fibroblasts as cellular therapy in plastic surgery. Clin Plast Surg. 2000 Oct; 27(4):613-26.
2000ǯȯɽ¡£ÊƹñIsolagen¼Ò¤¬¹Ô¤¦¡ÖÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¡×¤Ë¤è¤ë¼£ÎŤϡ¢3000¿Í°Ê¾å¤Ë¼£ÎŤò¹Ô¤¤Èó¾ï¤ËÎɹ¥¤Ê·ë²Ì¤òÆÀ¤Æ¤¤¤ë
»²¹ÍÏÀʸ02¡ä

3) Boss WK Jr, Usal H, Fodor PB, Chernoff G. Autologous cultured fibroblasts: a protein repair system. Ann Plast Surg. 2000 May; 44(5):536-42.
2000ǯȯɽ¡£ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤Ë¤è¤ë¼£ÎŤϡ¢ÈéÉæ¤ÎⲤÀ¤±¤Ç¤Ï¤Ê¤¯¡¢¤Ë¤­¤Ó¤äÇ¥¿±Àþ¤Ë¤âÍ­¸ú¤Ç¤¢¤ë¡£¤³¤ì¤é¤Î»ö¼Â¤Ï¸½ºß¤Þ¤Ç¤Ë¥¢¥á¥ê¥«¤À¤±¤Ç1450¿Í¡¢¥è¡¼¥í¥Ã¥Ñ¤ò´Þ¤á¤¿Á´À¤³¦¤Ç4800¿Í¤¬ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤Ë¤è¤ë¼£ÎŤò¼õ¤±¤Æ¤¤¤ë¡£¤³¤Î¼£ÎŤγؽÑŪ¤ËÃæ¿´¤È¤Ê¤Ã¤¿Âç³Ø¤Ï¡¢ÊƹñNew JerseyÂç³Ø°å³ØÉô¡¢HackensackÂç³Ø°å³ØÉô¤Ç¡¢94¿Í¤ÎĹ´ü¥Õ¥©¥í¡¼¡Ê3ǯ¡½4ǯ¡Ë¤ò¹Ô¤Ã¤¿¡£92%¤Ë¤â¾å¤ë¿Í¤¬Ëþ­¤ÈÅú¤¨¡¢70%¤Î¿Í¤¬Ä¹´üŪ¤Ë¤âËþ­¤Î¤¤¤¯¼£ÎŤÈÅú¤¨¤¿¡£
»²¹ÍÏÀʸ03¡ä

4) Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg. 2007 Mar; 33(3):263-8.
2007ǯȯɽ¡£ÇÝÍܤ·¤¿¼«Ê¬¼«¿È¤Î¿¿ÈéÀþ°Ý²êºÙ˦¤¬¡¢´é¤Î¤·¤ï¡¦¤¿¤ë¤ß¡¢´ÙËפʤɤËÍ­¸ú¤Ê¼£ÎŤǤ¢¤ë¤È¤¤¤¦Êó¹ð¡¦¾ÉÎ㤬¸½ºß¡Ê2007ǯ»þÅÀ¡Ë¤Þ¤Ç¿ô¿¤¯¤Ê¤µ¤ì¤Æ¤­¤Æ¤¤¤ë¡£ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤Ë¤è¤ë¼£ÎŤ¬Êƹñ¤ÇÀµ¼°¤Ê¼£ÎŤȤʤ뤿¤á¤ËFDA¡ÊÊÆ¹ñ¸üÏ«¾Ê¡Ë¤Ë¿½ÀÁ¤¹¤ëºÇ½ªÎ×¾²¼£¸³¡Ê¥Õ¥§¡¼¥º£³¡Ë¤ò¹Ô¤¤¤Ã¤¿¡£Î×¾²»î¸³¤Ï¸·³Ê¤ËFDA¡ÊÊÆ¹ñ¸üÏ«¾Ê¡Ë¤Îµá¤á¤ëÆó½ÅÌÕ¸¡Ë¡¡ÊÃí¡Ë¤ò215¾ÉÎã¤Ë¹Ô¤¤¡¢°ÂÁ´À­¡¦Í­¸úÀ­¤ËÂФ·¤ÆÈó¾ï¤ËÎɹ¥¤Ê·ë²Ì¤òÆÀ¤¿¡£

Ãí¡ËÆó½ÅÌÕ¸¡Ë¡¡§³°¸«¤«¤é¤Ï¸«Ê¬¤±¤Î¤Ä¤«¤Ê¤¤¡¢­¡ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤ÎÆþ¤Ã¤¿Ãí¼Í¤È¡¢­¢ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤ÎÆþ¤Ã¤Æ¤¤¤Ê¤¤Ãí¼Í¤òÍѰդ·¡¢¸¡ºº¥³¡¼¥Ç¥£¥Í¡¼¥¿¡¼¤À¤±¤¬¡¢¤É¤Î´µ¼Ô¤ËËÜʪ¤Î¼£Îšʭ¡¡Ë¤ò¤·¤¿¤«¤òÃΤäƤ¤¤ë¡£¼£ÎÅ´µ¼Ô¤Ï¤â¤Á¤í¤ó¼£ÎÅôÅö°å»Õ¤â¡¢¼«Ê¬¤¬»È¤Ã¤Æ¤¤¤ëÃí¼Í´ï¤¬ËÜʪ¡Ê­¡¡Ë¤«¡¢µ¶¼Ô¡Ê­¢¡Ë¤«ÃΤ餺¤Ë¼£ÎŤò¤·¡¢¼£ÎŤò¼õ¤±¤Æ¤¤¤ë¤¿¤á¡¢Ê諤ËÏǤ蘆¤ì¤ë¤³¤È̵¤¯¡¢ËÜʪ¤ÎÀµ³Î¤Ê¼£ÎŸú²Ì¬Ä꤬¤Ç¤­¤ë¡£
»²¹ÍÏÀʸ04¡ä

5) Zhao Y, Wang J, Yan X, Li D, Xu J. Preliminary survival studies on autologous cultured skin fibroblasts transplantation by injection. Cell Transplant. 2008; 17(7):775-83.
ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤Ë¤è¤ë¼£ÎŤÏÈéÉæ¤Ë¤É¤ÎÄøÅ٤Υ³¥é¡¼¥²¥ó¤òºî¤ë¤Î¤«¥¦¥µ¥®¤òÍѤ¤¤¿Æ°Êª¼Â¸³¤ò¹Ô¤Ã¤¿¡£¥¦¥µ¥®¤Î¼£ÎÅÉô°Ì¤òºÎ¼è¤·¡¢¸²Èù¶À¤Ç¤Î¸¡ºº¤ò¹Ô¤Ã¤¿¡£·ë²Ì¤Ï¥¿¥¤¥×£±·¿¥³¥é¡¼¥²¥ó¤è¤ê¤â¡¢3·¿¥³¥é¡¼¥²¥ó¤¬Â¿¤«¤Ã¤¿¡£ÈéÉæ¤ÎÂ礭¤Ê¤·¤ï¤Ï£±·¿¥³¥é¡¼¥²¥ó¤¬´ØÍ¿¤·¡¢ºÙ¤«¤Ê¤·¤ï¤Ï3·¿¥³¥é¡¼¥²¥ó¤¬´ØÍ¿¤·¤Æ¤¤¤ë¤¿¤á¡¢ÇÝÍܤ·¤¿¼«¸Ê¿¿ÈéÀþ°Ý²êºÙ˦¤Ë¤è¤ê¼£ÎŤϡ¢ºÙ¤«¤Ê¤·¤ï¡Ê¤Á¤ê¤á¤óⲡˤˤè¤êÍ­¸ú¤Ç¤¢¤ë¤È¹Í¤¨¤é¤ì¤ë¡£
»²¹ÍÏÀʸ05¡ä

6) ÇÝÍÜ¿¿ÈéÀþ°Ý²êºÙ˦°Ü¿¢¤Ë¤è¤ë´éÌÌÈéÉæ¤Î¼ãÊÖ¤ê½Ñ
»²¹ÍÏÀʸ06¡ä